Pfizer (PFE) Dividends Paid - Common (2009 - 2026)

Pfizer (PFE) has 18 years of Dividends Paid - Common data on file, last reported at $2.4 billion in Q1 2026.

• Dividends Paid - Common for Q1 2026 came in at $2.4 billion, changed 0.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.8 billion (down 31.72% YoY), and the FY2025 annual result was $9.8 billion, up 2.72% from the prior year.
• Dividends Paid - Common steadied at $2.4 billion in Q1 2026 per PFE's latest filing, from $2.4 billion in the prior quarter.
• Over five years, Dividends Paid - Common peaked at $7.1 billion in Q3 2024 and troughed at $2.2 billion in Q3 2022.
• A 5-year average of $3.0 billion and a median of $2.4 billion in 2024 frame the typical range for Dividends Paid - Common.
• The sharpest annual moves came in 2024 and 2025: Dividends Paid - Common jumped 208.21% in 2024, then sank 65.73% in 2025.
• A 5-year view of Dividends Paid - Common shows it stood at $6.7 billion in 2022, then tumbled by 65.64% to $2.3 billion in 2023, then surged by 208.08% to $7.1 billion in 2024, then plunged by 65.72% to $2.4 billion in 2025, then changed by 0.0% to $2.4 billion in 2026.
• Business Quant data shows PFE's Dividends Paid - Common at $2.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.